Cord Blood America's New Medical Director Says Parkinson's, Diabetes Among Diseases to be Treated With Umbilical Cord Blood Stem Cells

Written by Cord Blood America, Inc.

LAS VEGAS, March 9 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com), is focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally. Its new Director of the Medical Advisory Board, Shamoon Ahmad, M.D., M.B.A., FACP, was interviewed about the stem cell revolution in medical care by analyst Francis Gaskins.

The entire interview is available at http://gaskinsco.com/cbai-3-8-10-b.mp3

Dr. Ahmad said he believes that stem cells preserved from the umbilical cord at birth will be used to treat Parkinson's disease, diabetes and muscular sclerosis, among other chronic diseases, which, he said, are amenable to cord blood transplants. Currently more than 70 diseases, including childhood leukemia and sickle cell anemia, are treated with these preserved stem cells.

The interview also features information about Dr. Ahmad's background, including that he established the first, and only, bone marrow transplantation facility in Nevada. He also is a registered investigator with the National Cancer Institute.

Dr. Ahmad explained that his new position means he will oversee the medical requirements of Cord Blood America's program and its quality. "We are looking for innovation," Dr. Ahmad said, explaining that the Company is a pioneer in stem cell storage and will soon add other biologic storage and preservation at its new Las Vegas facility.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com . For investor information, visit www.cordblood-america.com.

CONTACT:
Paul Knopick
E & E Communications
949-707-5365
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

SOURCE Cord Blood America, Inc. Media Contact: Paul Knopick of E & E Communications for Cord Blood America, Inc., +1-949-707-5365 This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Web Site: http://www.cordblood-america.com